featured
Applying Guidelines for Use of SGLT2is and GLP1-RAs as First-line Monotherapy or Add-on Therapy in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology–Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland
Diabetes Care 2020 Jun 24;[EPub Ahead of Print], TM Caparrotta, LAK Blackbourn, SJ McGurnaghan, J Chalmers, R Lindsay, R McCrimmon, J McKnight, S Wild, JR Petrie, S Philip, PM McKeigue, DJ Webb, N Sattar, HM ColhounFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.